Disease-Modifying Antirheumatic Drug Initiation Among Patients Newly Diagnosed With Rheumatoid ArthritisByMachaon Bonafede, PhD, MPH,Barbara H. Johnson, MBA,Neel Shah, PhD, BPharm,David J. Harrison, PhD,Derek Tang, PhD, BSPharm,Bradley S. Stolshek, PharmDJuly 10th 2018Only slightly more than half of patients with newly diagnosed rheumatoid arthritis initiated therapy within 1 year.